Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anne M. Skalicky, Anne M. Rentz, Zhimei Liu, Qayyim Said, Jo Anne Nakagawa, Michael D. Frost, James W. Wheless & David W. Dunn. (2018) Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families. Journal of Medical Economics 21:10, pages 953-959.
Read now
Read now
Xue Song, Zhimei Liu, Katherine Cappell, Christopher Gregory, Qayyim Said, Judith Prestifilippo, Hearns Charles, John Hulbert & John Bissler. (2017) Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma. Journal of Medical Economics 20:4, pages 388-394.
Read now
Read now
John C. Kingswood, Paola Nasuti, Keyur Patel, Melissa Myland, Vathani Siva & Elizabeth Gray. (2016) The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD). Journal of Medical Economics 19:12, pages 1116-1126.
Read now
Read now
Articles from other publishers (24)
Jami Kronick, Manal Y. Gabril & Andrew A. House. (2023) Microscopic Kidney Disease in Tuberous Sclerosis Complex and Treatment With mTOR Inhibition. American Journal of Kidney Diseases.
Crossref
Crossref
Athar Amleh, Hadass Pri Chen, Lana Watad, Ifat Abramovich, Bella Agranovich, Eyal Gottlieb, Iddo Z. Ben-Dov, Morris Nechama & Oded Volovelsky. (2023) Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model. Cell Reports Medicine 4:6, pages 101073.
Crossref
Crossref
Stephanie Vanclooster, Stacey Bissell, Agnies M. van Eeghen, Nola Chambers, Liesbeth De Waele, Anna W. Byars, Jamie K. Capal, Sebastián Cukier, Peter Davis, Jennifer Flinn, Sugnet Gardner-Lubbe, Tanjala Gipson, Tosca-Marie Heunis, Dena Hook, J. Christopher Kingswood, Darcy A. Krueger, Aubrey J. Kumm, Mustafa Sahin, Eva Schoeters, Catherine Smith, Shoba Srivastava, Megumi Takei, Robert Waltereit, Anna C. Jansen & Petrus J. de Vries. (2022) The research landscape of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND)—a comprehensive scoping review. Journal of Neurodevelopmental Disorders 14:1.
Crossref
Crossref
Noelle K X Chung, Peter Metherall, Janet A McCormick, Roslyn J Simms & Albert C M Ong. (2022) Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response. Clinical Kidney Journal 15:6, pages 1160-1168.
Crossref
Crossref
Efthymia Vargiami, Stella Stabouli, Christina Sidira, Maria Kyriazi, Athanasia Anastasiou, Athanasios Notopoulos & Dimitrios Zafeiriou. (2022) Blood pressure and glomerular filtration rate in youth with tuberous sclerosis complex. European Journal of Pediatrics 181:4, pages 1465-1472.
Crossref
Crossref
Janina Grau, Johann Philipp Zöllner, Susanne Schubert-Bast, Gerhard Kurlemann, Christoph Hertzberg, Adelheid Wiemer-Kruel, Thomas Bast, Astrid Bertsche, Ulrich Bettendorf, Barbara Fiedler, Andreas Hahn, Hans Hartmann, Frauke Hornemann, Ilka Immisch, Julia Jacobs, Matthias Kieslich, Karl Martin Klein, Kerstin A. Klotz, Gerhard Kluger, Markus Knuf, Thomas Mayer, Klaus Marquard, Sascha Meyer, Hiltrud Muhle, Karen Müller-Schlüter, Anna H. Noda, Susanne Ruf, Matthias Sauter, Jan-Ulrich Schlump, Steffen Syrbe, Charlotte Thiels, Regina Trollmann, Bernd Wilken, Laurent M. Willems, Felix Rosenow & Adam Strzelczyk. (2021) Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort study. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Johann Philipp Zöllner, Janina Grau, Felix Rosenow, Matthias Sauter, Markus Knuf, Gerhard Kurlemann, Thomas Mayer, Christoph Hertzberg, Astrid Bertsche, Ilka Immisch, Karl Martin Klein, Susanne Knake, Klaus Marquard, Sascha Meyer, Anna H. Noda, Felix von Podewils, Hannah Schäfer, Charlotte Thiels, Laurent M. Willems, Bianca Zukunft, Susanne Schubert-Bast & Adam Strzelczyk. (2021) Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Elieser Hitoshi Watanabe, Fernando Morbeck Almeida Coelho, Hilton Leão Filho, Bruno Eduardo Pedroso Balbo, Precil Diego Miranda de Menezes Neves, Fernanda Maria Franzin, Fernando Ide Yamauchi & Luiz Fernando Onuchic. (2021) The effect of sirolimus on angiomyolipoma is determined by decrease of fat-poor compartments and includes striking reduction of vascular structures. Scientific Reports 11:1.
Crossref
Crossref
Johann Philipp Zöllner, David Neal Franz, Christoph Hertzberg, Rima Nabbout, Felix Rosenow, Matthias Sauter, Susanne Schubert-Bast, Adelheid Wiemer-Kruel & Adam Strzelczyk. (2020) A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC). Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Cécile M. Champy, Riccardo Campi, Pietro Grande, Alexandre de la Taille, Arnaud Méjean, Benjamin Granger, Marc-Olivier Bitker & Morgan Rouprêt. (2020) How many surgically-treated angiomyolipomas are related to tuberous sclerosis complex? Insights from a retrospective multicenter study. Minerva Urologica e Nefrologica 72:2.
Crossref
Crossref
Wenda Wang, Xu Wang, Hao Guo, Yi Cai, Yushi Zhang & Hanzhong Li. (2020) PTEN inhibitor VO‑OHpic suppresses TSC2‑/‑ MEFs proliferation by excessively inhibiting autophagy via the PTEN/PRAS40 pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Menno Vergeer, Wendela L. Ranitz‐Greven, Maureen P. Neary, Raluca Ionescu‐Ittu, Bruno Emond, Mei Sheng Duh, Floor Jansen & Bernard A. Zonnenberg. (2019) Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex. Epilepsia Open 4:4, pages 581-592.
Crossref
Crossref
Ruben Marques, Elena Belousova, Mirjana P. Benedik, Tom Carter, Vincent Cottin, Paolo Curatolo, Maria Dahlin, Lisa D'Amato, Guillaume Beaure d'Augères, Petrus J. de Vries, José C. Ferreira, Martha Feucht, Carla Fladrowski, Christoph Hertzberg, Sergiusz Jozwiak, John A. Lawson, Alfons Macaya, Rima Nabbout, Finbar O'Callaghan, Jiong Qin, Valentin Sander, Matthias Sauter, Seema Shah, Yukitoshi Takahashi, Renaud Touraine, Sotiris Youroukos, Bernard Zonnenberg, John C. Kingswood & Anna C. Jansen. (2019) Treatment Patterns and Use of Resources in Patients With Tuberous Sclerosis Complex: Insights From the TOSCA Registry. Frontiers in Neurology 10.
Crossref
Crossref
John J Bissler, Klemens Budde, Matthias Sauter, David N Franz, Bernard A Zonnenberg, Michael D Frost, Elena Belousova, Noah Berkowitz, Antonia Ridolfi & J Christopher Kingswood. (2019) Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2. Nephrology Dialysis Transplantation 34:6, pages 1000-1008.
Crossref
Crossref
Angela Volpi, Gabriele Sala, Elena Lesma, Francesca Labriola, Marco Righetti, Rosa Maria Alfano & Mario Cozzolino. (2018) Tuberous sclerosis complex: new insights into clinical and therapeutic approach. Journal of Nephrology 32:3, pages 355-363.
Crossref
Crossref
Anne M. Rentz, Anne M. Skalicky, Zhimei Liu, David W. Dunn, Michael D. Frost, Jo Anne Nakagawa, Judith Prestifilippo, Qayyim Said & James W. Wheless. (2018) Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey. Journal of Patient-Reported Outcomes 2:1.
Crossref
Crossref
Akira Ashida, Hideki Matsumura, Yuko Fujii, Hyogo Nakakura, Akihiko Shirasu & Hiroshi Tamai. (2018) Everolimus improved renal function without reducing the size of a kidney angiomyolipoma in a patient with tuberous sclerosis complex: a case report. Renal Replacement Therapy 4:1.
Crossref
Crossref
Peter Janssens, Karen Van Hoeve, Liesbeth De Waele, Stéphanie De Rechter, Kathleen J. Claes, Els Van de Perre, Karl Martin Wissing, Bert Bammens, Anna Jansen & Djalila Mekahli. (2018) Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study. Pediatric Nephrology 33:11, pages 2085-2093.
Crossref
Crossref
J. L. H. Ruud Bosch, Francis Vekeman, Mei Sheng Duh, Maureen Neary, Matthew Magestro, Jonathan Fortier, Paul Karner, Raluca Ionescu-Ittu & Bernard A. Zonnenberg. (2018) Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center. International Urology and Nephrology 50:3, pages 459-467.
Crossref
Crossref
Wei-Chung Hsiao, Jeng-Dau Tsai, Shao-Chun Wang & Sung-Lang Chen. (2018) Mammalian target of rapamycin inhibitor and transarterial embolization for treatment of tuberous sclerosis complex patients with renal angiomyolipoma. Urological Science 29:2, pages 100.
Crossref
Crossref
S. Brakemeier, F. Bachmann & K. Budde. (2016) Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients. Pediatric Nephrology 32:7, pages 1137-1144.
Crossref
Crossref
Yi Cai, Hanzhong Li & Yushi Zhang. (2017) Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China. Urology 101, pages 170.e1-170.e7.
Crossref
Crossref
Raouf Seyam, Waleed Al Khudair, Said A. Kattan, Mohammed Faihan Al Otaibi, Fawaz Skaff & Waleed Mohamad Al Taweel. (2016) The impact of renal angiomyolipoma on estimated glomerular filtration rate in patients with tuberous sclerosis complex. Annals of Saudi Medicine 36:5, pages 356-363.
Crossref
Crossref
J. Chris Kingswood, John J. Bissler, Klemens Budde, John Hulbert, Lisa Guay-Woodford, Julian R. Sampson, Matthias Sauter, Jane Cox, Uday Patel, Frances Elmslie, Chris Anderson & Bernard A. Zonnenberg. (2016) Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future Study. Nephron 134:2, pages 51-58.
Crossref
Crossref